U.S. Pediatric Cancer Biomarker Market Size & Outlook
The pediatric cancer biomarker market in the United States is expected to reach a projected revenue of US$ 497.7 million by 2030. A compound annual growth rate of 8.1% is expected of the United States pediatric cancer biomarker market from 2025 to 2030.
Revenue, 2024 (US$M)
$311.8
Forecast, 2030 (US$M)
$497.7
CAGR, 2025 - 2030
8.1%
Report Coverage
U.S.
Related Markets
U.S. pediatric cancer biomarker market highlights
- The U.S. pediatric cancer biomarker market generated a revenue of USD 311.8 million in 2024 and is expected to reach USD 497.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.1% from 2025 to 2030.
- In terms of segment, leukemia was the largest revenue generating indication in 2024.
- CNS Tumors is the most lucrative indication segment registering the fastest growth during the forecast period.
Pediatric cancer biomarker market data book summary
| Market revenue in 2024 | USD 311.8 million |
| Market revenue in 2030 | USD 497.7 million |
| Growth rate | 8.1% (CAGR from 2025 to 2030) |
| Largest segment | Leukemia |
| Fastest growing segment | CNS Tumors |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CNS Tumors, Leukemia, Neuroblastoma, Lymphona |
| Key market players worldwide | Roche Holding AG, Abbott Laboratories, Siemens Healthineers AG ADR, Thermo Fisher Scientific Inc, Qiagen NV, Myriad Genetics Inc, Beckman Coulter, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, RayBiotech, Randox |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.3% of the global pediatric cancer biomarker market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. pediatric cancer biomarker market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 98.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pediatric Cancer Biomarker Market Scope
Pediatric cancer biomarker market segmentation & scope
Others
Pediatric Cancer Biomarker Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| RayBiotech | View profile | 101-250 | Norcross, Georgia, United States, North America | http://www.raybiotech.com/ |
| Randox | View profile | 1001-5000 | Crumlin, Antrim, United Kingdom, Europe | http://www.randox.com |
| Beckman Coulter | View profile | 10001+ | Brea, California, United States, North America | http://www.beckmancoulter.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
U.S. pediatric cancer biomarkers market size, by indication, 2018-2030 (US$M)
U.S. Pediatric Cancer Biomarker Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
